Skip to main content
AVTRAvantor, Inc.Sell5.2·$11.44+0.79%
SellModerate Confidence
Investment thesis

Quality well below the minimum threshold and a confirmed technical downtrend—reinforced by a death cross hard block—combine to create a risk/reward of roughly 0.21 to 1, leaving this setup with more downside exposure than upside potential at current prices.

Thesis pillars

  • Quality Below Minimum FloorStable
  • Confirmed Downtrend Death Cross BlockStable
  • Elevated Put Call Bearish PositioningDeteriorating
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Avantor, Inc. (AVTR) Stock Analysis

Momentum Cont setup

SellVALUE-TRAP 1/5ValueGrowthModerate Confidence

Healthcare · Medical Instruments & Supplies

Earnings in 3 days (2026-07-29). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Engine safety override at $11.44: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality.

Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil silicone, and Masterflex fluid systems — to 300,000+ customer locations in ~180 countries through Laboratory Solutions and Bioscience Production segments. The... Read more

$11.44-17.9% A.UpsideScore 5.2/10#22 of 32 Medical Instruments & Supplies
QualityF-score8 / 9FCF yield6.27%
Stop $10.64Target $11.52(resistance)A.R:R -1.2:1
Analyst target$10.44-8.8%16 analysts
$11.52our TP
$11.44price
$10.44mean
$7
$19

Sell if holding. Engine safety override at $11.44: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 63, MACD bullish. Score 5.2/10, moderate confidence.

Passes 5/9 gates (positive momentum, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 3d<=7d. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-26

Recent Developments — Avantor, Inc.

Generated 2026-07-26T09:22:59Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 20263d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Supplier: sole-sourced raw materials
Target reached (-17.9% upside)
Quality below floor (3.1 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)13.4
Mkt Cap$7.8B
EV/EBITDA12.0
Profit Mgn-8.4%
ROE-9.4%
Rev Growth0.0%
Beta0.94
DividendNone
Rating analysts25

Quality Signals

Piotroski F8/9

Options Flow

P/C0.07bullish
IV76%elevated

Concentration Risks(10-K Item 1A)

  • HIGHSuppliersole-sourced raw materials
    10-K Item 1A: 'raw materials, many of which are sole-sourced due to market or customer demands'

Material Events(8-K, last 90d)

  • 2026-04-01Item 5.02HIGH
    CFO R. Brent Jones resigned March 26, 2026 to join a company outside life sciences (90-day notice required). SVP/CAO Steven Eck named interim CFO; executive search for permanent CFO underway. No permanent successor named.
    SEC filing →
  • 2026-04-23Item 5.02MEDIUM
    EVP Benoit Gourdier notified April 17, 2026 of transition to segment integration role, expected to depart by Dec 31, 2026. Successor Ludovic Brellier named EVP Bioscience and Medtech Products and Chief Transformation Officer, effective May 1, 2026.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
1.2
Support Resistance
1.5
52w Position
4.4

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
1.1
Erm
2.5
Surprise Avg
3.1
Earnings Timing
5.0
Estimates down -16.9% (30d)Earnings concerns: 1B/2MEarnings in 3 days

Unprofitable operations — net margin -8.4%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Roa
1.9
Gross Margin
2.4
Operating Margin
2.5
Moat
3.2
Current Ratio
6.3
Piotroski F
8.9
No competitive moatStrong Piotroski F-Score: 8/9

Negative sentiment — recent news tone and/or analyst downgrades drag the composite below neutral.static

Erm Sentiment
0.0
Price Target
3.7
Analyst Rating
5.0
Estimates falling as sentiment proxy (-16.9%)
GatesA.R:R -1.2=NEGATIVEEARNINGS PROXIMITY 3d<=7dDeath cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 7.0>=5.5Insider activity: OKNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARMomentum ContSuitability: Moderate
RSI
63 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $9.72Resistance $11.75

Price Targets

$11
$12
A.Upside-17.9%
A.R:R-1.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-17.9% upside)
! Quality below floor (3.1 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-07-29 (3d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AVTR stock a buy right now?

Sell if holding. Engine safety override at $11.44: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 63, MACD bullish. Prior stop was $10.64. Score 5.2/10, moderate confidence.

What is the AVTR stock price target?

Take-profit target: $11.52 (-17.9% upside). Prior stop was $10.64. Stop-loss: $10.64.

What are the risks of investing in AVTR?

Concentration risk — Supplier: sole-sourced raw materials; Target reached (-17.9% upside); Quality below floor (3.1 < 4.0).

Is AVTR overvalued or undervalued?

Avantor, Inc. trades at a P/E of N/A (forward 13.4). TrendMatrix value score: 7.1/10. Verdict: Sell.

What do analysts say about AVTR?

25 analysts cover AVTR with a consensus score of 2.8/5. Average price target: $10.

What does Avantor, Inc. do?Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil...

Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil silicone, and Masterflex fluid systems — to 300,000+ customer locations in ~180 countries through Laboratory Solutions and Bioscience Production segments. The company generates revenue through distribution and service contracts, with ~80% of 2025 transactions via digital channels and no single customer exceeding 5% of net sales.

Related stocks: WST (West Pharmaceutical Services, I) · STAA (STAAR Surgical Company) · NVST (Envista Holdings Corporation) · RMD (ResMed Inc.) · TFX (Teleflex Incorporated)
Home Stocks AVTR

Latest news

Latest News

Benzinga18d agoAnalyst
Benzinga20d agoAnalyst
Benzinga30d agoAnalyst
Benzinga32d agoAnalyst
Benzinga48d ago
Benzinga54d ago
Benzinga59d ago
Benzinga72d agoAnalyst
Benzinga87d agoAnalyst
Benzinga87d agoAnalyst
Benzinga88d agoEarnings
Benzinga88d agoEarnings
Benzinga88d agoEarnings
Benzinga88d ago
Benzinga102d agoAnalyst
Benzinga104d agoProduct
Benzinga108d ago